Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP) [Phase 2]
A Phase 2 study evaluated whether adding exposure and response prevention to ketamine could extend its effects for obsessive-compulsive diso…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD) [Phase 2]
Phase 2 pilot study evaluating ketamine in adults with obsessive-compulsive disorder has completed. Results were posted on 2016-10-27.
-
CLINICAL_TRIALS research · 2016-10-26Clinical Trial Update: Examining the Feasibility and Acceptability of Good Quality Intensive CBT for OCD and Good Quality Weekly CBT for OCD [NA]
This clinical trial update reports on a study evaluating the feasibility and acceptability of Good Quality Intensive CBT versus Good Quality…
-
FDA approval · 2016-10-21FDA Approved: FLUOXETINE — Original Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's original application for fluoxetine, authorizing the marketing of a generic fluoxetine pr…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Obsessive-Compulsive Disorder [EARLY_Phase 1]
This document provides an early-phase 1 trial update on the long-term safety and efficacy of the PINS Stimulator System for Obsessive-Compul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-10-14Clinical Trial Update: Effect of Mindfulness Based Treatment for Obsessive-compulsive Disorder [NA]
A clinical trial evaluating mindfulness-based treatment for obsessive-compulsive disorder sponsored by Seoul National University Hospital ha…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Brief Behavioral Treatment for Anxiety in Young Children [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1 and Phase 2 evaluations of Brief Behavioral Treatment for Anxiety in young chil…
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
A clinical trial update presenting an individual patient data meta-analysis assessing baseline severity and antidepressant efficacy across s…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Internet Delivered CBT for OCD in Adolescents With ASD - A Clinical Case Series [NA]
This completed clinical case series evaluates internet-delivered cognitive behavioral therapy for obsessive-compulsive disorder in adolescen…
-
CLINICAL_TRIALS research · 2016-08-30Clinical Trial Update: Developing Computerised CBT for Adults With OCD [EARLY_Phase 1]
Early-phase trial investigating computerised cognitive behavioural therapy for adults with obsessive-compulsive disorder. The status of the …
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Treatment of Obsessive-Compulsive Disorder (OCD) in Children [Phase 3]
A Phase 3 pediatric obsessive-compulsive disorder trial sponsored by the University of Pennsylvania has completed.
-
FDA approval · 2016-08-19FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Endo USA, Inc.)
FDA approves Endo USA, Inc.'s fluoxetine hydrochloride as an Original Application, providing a generic version of fluoxetine hydrochloride.
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Development of an Instrument That Monitors Behaviors Associated With OCD
The clinical trial evaluating an instrument for monitoring behaviors associated with obsessive-compulsive disorder has completed.
-
FDA approval · 2016-08-01FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approves a supplemental application for PROZAC (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS research · 2016-08-01Clinical Trial Update: Inhibitory Control of the Mind : Neural Bases and Impact for Obsessive-compulsive Disorders [NA]
A clinical trial from University Hospital Caen is examining the neural bases of inhibitory control and its relevance to obsessive-compulsive…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy [Phase 2]
Phase 2 study evaluating AFQ056 in obsessive-compulsive disorder patients resistant to SSRI therapy was terminated; results were posted in 2…
-
FDA approval · 2016-06-10FDA Approved: PAROXETINE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original ANDA for paroxetine (paroxetine hydrochloride), establishing a generic version of the antidepr…
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: Stepped Care for Treating Obsessive-Compulsive Disorder [NA]
Completed clinical trial evaluating stepped care for obsessive-compulsive disorder with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Comparison of DBS Targets in Obsessive-compulsive Disorder [Phase 3]
This update indicates the Phase 3 trial comparing different deep brain stimulation targets for obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Neuropsychological Profiles of Pediatric Obsessive Compulsive Disorder (OCD) [NA]
A pediatric OCD neuropsychology trial sponsored by the University of Texas at Austin has been terminated.
-
CLINICAL_TRIALS research · 2016-05-06Clinical Trial Update: Internet-delivered Transdiagnostic Intervention for Anxiety and Depression [NA]
This clinical trial update describes an internet-delivered transdiagnostic intervention for anxiety and depression, covering multiple disord…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder [Phase 2]
Phase 2 trial evaluating riluzole augmentation in treatment-refractory obsessive-compulsive disorder has completed with results posted in 20…
-
FDA approval · 2016-03-14FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, enabling the commercialization of a gene…
-
FDA approval · 2016-03-14FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
The FDA approved a supplemental application from Quallent Pharmaceuticals Health LLC to market fluoxetine hydrochloride as a generic product…
-
CLINICAL_TRIALS research · 2016-03-11Clinical Trial Update: Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders
A completed clinical study from Rhode Island Hospital evaluated how parenting styles and child temperament relate to anxiety disorders and o…